Cymbalta vs. Celexa

See how Cymbalta and Celexa compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Cymbalta is an SNRI approved for depression, anxiety, and several chronic pain conditions, while Celexa is an SSRI approved only for major depressive disorder in adults.

  • Both carry a boxed warning for increased suicidal thinking in young people, but Celexa also carries a dose-dependent QT prolongation warning that Cymbalta's label does not include.

  • Cymbalta's pain indications and twice-daily option make it useful beyond mood disorders, while Celexa's simple once-daily dosing suits straightforward depression treatment.

Cymbalta vs. Celexa Drug Summary

Cymbalta

Cymbalta (duloxetine) is a serotonin and norepinephrine reuptake inhibitor (SNRI) approved for depression, generalized anxiety, and chronic pain conditions like diabetic neuropathy and fibromyalgia. It is taken as a delayed-release capsule, typically once daily, with some patients splitting the dose twice a day at higher strengths.

Celexa

Celexa (citalopram) is a selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder in adults. It is taken as a once-daily tablet or oral solution, and clinicians also prescribe it off-label for anxiety and panic disorders despite lacking FDA approval for those uses.

Cymbalta vs. Celexa Side Effects

Cymbalta

Most common
nausea (up to 30%)
somnolence (up to 21%)
dry mouth (up to 15%)
headache (up to 18%)

Celexa

Most common
nausea (up to 21%)
somnolence (up to 18%)
dry mouth (up to 20%)
insomnia (up to 15%)

Cymbalta vs. Celexa Dosage

Cymbalta

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 30 mg once daily Week 1
Maximum dose 60 mg twice daily If needed
Dose changes 2 increases Every week

Celexa

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 20 mg once daily Week 1
Maximum dose 40 mg once daily Week 2 onward
Dose changes 1 increase Every week

Cymbalta vs. Celexa Indications

Cymbalta

Cymbalta treats major depressive disorder and generalized anxiety disorder, and it is also FDA-approved for several chronic pain conditions. This makes it a common choice when depression or anxiety occurs alongside diabetic nerve pain, fibromyalgia, or musculoskeletal pain.

  • Major depressive disorder

  • Generalized anxiety disorder

  • Diabetic peripheral neuropathic pain

  • Fibromyalgia

Celexa

Celexa is FDA-approved only for major depressive disorder in adults. It is frequently prescribed off-label for anxiety-related conditions, though those uses are not supported by an FDA label indication.

  • Major depressive disorder in adults

  • Generalized anxiety disorder (off-label)

  • Panic disorder (off-label)

  • Obsessive-compulsive disorder (off-label)

Cymbalta vs. Celexa Pros and Cons

Cymbalta

Cymbalta's SNRI action extends its use beyond depression into chronic pain management, giving it broader clinical utility than many antidepressants. It requires caution in patients with liver or significant kidney disease, and its side effect profile differs somewhat from standard SSRIs.

Pros

  • Approved for chronic pain conditions like diabetic neuropathy and fibromyalgia, not just mood disorders

  • Acts on both serotonin and norepinephrine, which can help pain and mood symptoms together

  • No QT prolongation warning on its label, unlike Celexa

Cons

  • Must be avoided in patients with chronic liver disease or severe kidney impairment

  • Higher rate of nausea reported than Celexa (up to 30% vs 21%)

  • Discontinuation symptoms can be more pronounced due to its dual-action mechanism

Celexa

Celexa is a long-established SSRI with decades of safety data and predictable once-daily dosing for adults with depression. Its main limitations are a dose ceiling tied to QT prolongation risk and lack of FDA approval for anxiety disorders that are often treated off-label.

Pros

  • Decades of established safety data as one of the most widely prescribed SSRIs

  • Simpler once-daily dosing without a twice-daily maintenance option to manage

  • Available in tablet and oral solution forms for patients who have trouble swallowing pills

Cons

  • Dose-dependent QT prolongation risk that limits doses above 40 mg per day

  • Not FDA-approved for anxiety, panic, or OCD despite common off-label use

  • Maximum dose capped at 20 mg for elderly patients, hepatic impairment, or poor metabolizers

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.